OPTIMI HEALTH CORP. (8BN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) has a cash flow conversion efficiency ratio of -0.127x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-636.99K ≈ $-744.70K USD) by net assets (€5.02 Million ≈ $5.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of OPTIMI HEALTH CORP. to measure how many days the company can operate on defensive assets alone.
OPTIMI HEALTH CORP. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how OPTIMI HEALTH CORP.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
OPTIMI HEALTH CORP. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OPTIMI HEALTH CORP. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZOONO Group Ltd
AU:ZNO
|
-0.356x |
|
Medicus Pharma Ltd. Common Stock
NASDAQ:MDCX
|
-4.559x |
|
Vereinigte Filzfabriken AG
MU:VFF
|
N/A |
|
African Media Entertainment
JSE:AME
|
0.070x |
|
M4B SA ZY 8
F:24D
|
N/A |
|
UMS-Neiken Group Bhd
KLSE:7227
|
0.090x |
|
Austem Company Ltd
KQ:031510
|
-0.003x |
|
Northeast Electric Development Company Limited
F:NE4H
|
0.009x |
Annual Cash Flow Conversion Efficiency for OPTIMI HEALTH CORP. (2022–2025)
The table below shows the annual cash flow conversion efficiency of OPTIMI HEALTH CORP. from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see OPTIMI HEALTH CORP. stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €6.57 Million ≈ $7.68 Million |
€-2.63 Million ≈ $-3.07 Million |
-0.400x | +10.56% |
| 2024-09-30 | €9.58 Million ≈ $11.20 Million |
€-4.28 Million ≈ $-5.01 Million |
-0.447x | -64.02% |
| 2023-09-30 | €13.21 Million ≈ $15.44 Million |
€-3.60 Million ≈ $-4.21 Million |
-0.273x | +4.63% |
| 2022-09-30 | €16.02 Million ≈ $18.73 Million |
€-4.58 Million ≈ $-5.35 Million |
-0.286x | -- |
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more